Aug 7

Adult Stem Cells Restore Lost Eyesight in ONA Patient Trelle [Video]

After getting into a car accident in eighth grade, Texas native Trelle Dandridge developed Optic Nerve Atrophy (ONA), which caused her vision to deteriorate over several years to the point where she had to resign from her dream job.

ONA is a mild to severe damage to the optic nerve that can adversely affect central vision, peripheral vision and color vision.

In Trelle’s case, she suffered head trauma in the car accident and shortly after experienced a strange sensation. “[I] noticed my head felt very, very large, abnormally large. My mom and sister who were also in the car accident said it looked fine, other than some cuts from glass.” Her mother, a nurse, monitored her and all seemed fine until her mother realized Trelle didn’t notice when she walked away from her at a grocery store.

Jul 28

Twins with Cerebral Palsy See Improvements from Stem Cell Treatment

Triplets Ali, Abdulla, and Mohamed were born premature at 25 weeks, all suffering from cerebral hemorrhaging. Due to the bleeding Ali passed away after 3 months. While the twins Abdulla and Mohamed survived, both had serious problems in the intensive care unit; Abdulla had a shunt but he was more stable than Mohamed whose brain white matter was effected by the bleeding. Both now live with Cerebral Palsy (CP) which greatly alters their quality of life and ability to live independently.

Thankfully, a trip to Better Being Hospital (BBH) for treatment with Beike Biotechnology adult stem cells has given them and their parents hope where there was none before, and both twins are seeing big changes in their spasticity, motor function, eyesight, and general behavior.

Jul 23

U.S. Spinal Cord Injury Patient Documenting His Stem Cell + Epidural Stimulation Treatment

Quadriplegic Jack Pearce is set to undergo a new medical procedure that he is hoping may transform his life. Jack and his wife Ellie arrived in Bangkok, Thailand on July 5th, 2015 for a procedure which utilizes an implanted epidural stimulator to allow Spinal Cord Injury (SCI) patients to voluntarily move their limbs. This procedure also includes adult mesenchymal stem cell therapy, which has had dramatic results in two previous patients with results showing in weeks rather than months as outlined by Dr. Torsak Tip-Pairote.

The epidural stimulator is the latest device produced by Medtronic, while the adult stem cells were produced by Beike Biotechnology and will be injected by intravenous injection and lumbar puncture via their SCI treatment protocol. Under this protocol, Jack will also be receiving the recommended physical and occupational therapy, nutrition counseling, hyperbaric oxygen therapy, acupuncture, transcranial magnetic stimulation, and aquatherapy under the functional medicine program provided with his stem cell treatment.

Jul 16

Allogeneic Adult Stem Cells Restore Endothelial Function in Heart Failure

Cardiovascular diseases are the leading cause for deaths globally. Recent studies show that allogeneic mesenchymal stem cells are able to restore endothelial function in heart failure by stimulating progenitor cells. Research such as this marks a significant turning point in the manner that heart failure is treated.

Heart failure is caused by a decrease in endothelial progenitor cell function, the circulating cells that give rise to the formation of new vessels, and vasodilation, the relaxation of muscles within cell walls to enable the widening of blood vessels. The self-renewing properties of mesenchymal stem cells mean that they enable endothelial progenitor cells to multiply. This improves the vascular reactivity, thus normalising the endothelial function in patients with heart failure.

Jul 8

Cord Blood Awareness Month – Why Is It Important?

July marks Cord Blood Awareness Month. With around 360,000 babies born every day, the amount of cord blood available has skyrocketed in the past decade. Cord blood banking is becoming an increasingly popular choice for expectant parents for their children to use in the future. So, what is cord blood banking and why is it useful?

For one, stem cells can be harvested from bone marrow, umbilical cord and blood that circulates within the body. Stem cells derived from umbilical cord blood are the most diverse of these options. These have the ability to differentiate into specific cell types within the body and can replace damaged cells, increase blood flow to specific areas, and reduce inflammation.

Jul 8

Adult Stem Cell Advocates Continue to Push for Treatments and Research

The obvious need for stem cell research and increasing public support has been highlighted regularly the last few years, and the reality is that this ‘future treatment’ is available now. More recently however, adult stem cell advocates are urging U.S. lawmakers to pass a re-authorization bill that would continue funding for cell transplant programs that utilize adult mesenchymal stem cells from bone marrow and cord blood to research and treat chronic conditions in the United States.

“These programs are examples of how the Congress can inspire innovation to bring cures to patients across America,” said one witness, Dr. Jeffrey W. Chell, CEO of the National Marrow Donor Program.
Chell and Dr. Joanne Kurtzberg, a professor at Duke University and director of the Carolina Cord Blood Bank, were among those who testified at a hearing titled “Examining Public Health Legislation,” convened June 25th by the House Energy and Commerce Committee’s health subcommittee.

Jul 2

Stem Cell Research Changing Perceptions as well as Lives

Treatments involving stem cells are saving lives globally. Legislations such as those examined in the U.S. last Thursday encourage awareness and innovation that surround stem cell treatments and therapies. Stem cell research is a fast-paced field with a focus on the utilisation of stem cells derived from umbilical cord blood and tissue. These adult stem cells can consequently be differentiated and engineered to target conditions that were previously considered untreatable. An improvement across the world in the approval of bills and legislations would pave the path to a greater understanding of this pioneering field. As a result, the future would see the influx of a greater variety of conditions being treated by stem cell research.

Jun 19

Update on Cerebral Palsy Patient Alex [Video]

In November of 2014 we documented Alexandru’s stem cell treatment for Cerebral Palsy. Six months after this treatment we received a home video from his parents showing him walking once again (see below).

As shown in our previous testimonial, Alex received stem cell treatment with Beike Biotechnology protocols 5 times in China, and the sixth time in Thailand. However, before coming to Thailand, he underwent a surgery to fix the rotation on his legs which ended up being a major setback in his mobility. That surgery had to be repeated 4 times with no results. So, the family once again chose stem cell therapy to recover what was lost.

Jun 17

ONH-SOD Patient Sees Quick Results from Stem Cell Treatment [Video]

While receiving stem cell therapy for Optic Nerve Hypoplasia & Septo-optic Dysplasia (ONH-SOD), Marina Alonzo was able to see color in her completely blind eye for the very first time. With both eyes, she was also able to read and recognize the colors of a green sign some 40 feet away. These improvements are not the first for Marina, and the family is certainly hoping they are not the last.

For some background on Marina’s condition and issues with ONH-SOD, her mother, Debbie Alonzo, provided us with a very detailed account:
“My daughter Marina was born with a midline brain defect called Optic Nerve Hypoplasia. At about 3 months old her father and I noticed that she was not making eye contact with us and seemed to almost look right through us. Her eyes were also always moving or rolling without any control. At 5 months the doctor referred us to a neurologist

May 26

Ataxia Patient with Incredible Stem Cell Treatment Success Seeks Second Treatment [Video]

In 2011 an Ataxia patient named Riaan Van Der Merwe underwent stem cell therapy with us in China. The results were astounding. In 2015 however, his condition is relapsing and he is now hoping to undergo high-dose stem cell therapy in Thailand.

As we know, Ataxia is a progressive condition which attacks the nervous system and may lead to symptoms such as poor coordination, unsteady walking and a tendency to stumble, difficulty with fine motor tasks such as eating, writing or buttoning a shirt, a change in speech, involuntary back-and-forth eye movements known as nystagmus, and difficulty swallowing.

Prior to stem cell treatment Riaan’s symptoms included severe motor dysfunction which severely limited his fine and general motor skills, speech, and made daily life difficult.

May 22

Diet Found to be a Leading Factor in ALS Diagnosis

According to new research on Amyotrophic Lateral Sclerosis (ALS), a patient’s diet is a leading factor in the development and treatment of this devastating motor neuron disease.

Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis

ALS has now been proven to be due in part at least to a yeast infection of the intestines that is transmitted to the brain and spinal cord via the blood. Once the yeast particulates and molecules get into the blood they may enter the spinal cord through a “spinal blood barrier break.”

Apr 28

Multiple Sclerosis Patient Sees Quick Results After Stem Cell Treatment

Multiple Sclerosis is not a condition that is easy to live with. There is currently no cure, and its progressive nature means that it will only continue to get worse unless actions are taken to treat the disease symptoms and slow the degeneration of the central nervous system.

Fortunately for a Russian patient named Regina Kornev, stem cell treatment has shown to be an effective option for MS patients. Regina received a combination of umbilical cord blood stem cells (UCBSC) and umbilical cord mesenchymal stem cells (UCMSC) and started seeing noticeable results within two days.

Apr 23

Stem Cell Treatment Cost & Quality Comparisons

Stem cell treatment is regularly in the news around the world. Mostly the topics revolve around safety, efficacy, or ethics. Lately however, the price of these treatments has also been highlighted. Our stem cell provider, Beike Biotechnology, recently released their new protocol in hopes of cutting treatment cost. Other treatment providers in the news have been advertising prices from 50,000 USD to 200,000 USD.

Despite the thousands of positive research papers and clinical trials showing the effectiveness of stem cells the treatment is not readily available in most countries, especially not at a reasonable price. In the USA for example, it is possible to receive a stem cell treatment for Multiple Sclerosis. The bad news is that it will cost around $125,000 per patient, not including any drugs or supportive therapies. Also, this type of cell therapy (hematopoietic stem cell transplant) “is not effective in progressive MS.”

Apr 23

Personalized Nutrition Counseling at Better Being Hospital

At Better Being Hospital one of the first questions Dr. Torsak asks patients is, “How is your diet?” While this may sound strange to some, it is a vital question when it comes to treating chronic conditions systemically. In addition to being monitored by a team of nutritionists, our patients receive cooking classes to learn how to prepare the perfect meal for each person’s unique condition when they are back home. The diet in the hospital is then customized for each patient and is prepared on the basis of blood tests that are performed on the first day of treatment.
Meals for our patients are included in the treatment package, consisting of breakfast, lunch, and dinner, and are all prepared in the hospital’s own kitchen which uses hand selected products to ensure quality. A balanced diet comes daily with a label including the names of the patient and how many calories they are consuming, according to their specific energy needs.

Apr 13

High-dose Stem Cell Therapy™ for Degenerative Conditions

Beike Biotechnology is recommending a new protocol for degenerative conditions utilizing higher quantities of umbilical cord derived adult stem cells. The treatment reduces both the time and cost required due to less injections with each packet containing a more concentrated amount of cells. This treatment protocol then contains 200 million umbilical cord derived stem cells in total and can be done in a minimum of eight (8) days. The treatment includes both intravenous injections (IV) and lumbar puncture (LP) of both mesenchymal stem cells (MSCs) and umbilical cord blood stem cells (UCBSCs).

This new high-dose protocol was designed specifically for patients with degenerative conditions such as Ataxia, Liver Cirrhosis, Motor Neuron Diseases (MND), Multiple Sclerosis (MS) and Systemic Lupus Erythematosus (SLE).